Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-02-28
1992-03-10
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31425
Patent
active
050950274
ABSTRACT:
The present invention provides a method for treating and/or reducing ischemic reperfusion injury. To this end, in embodiment, a method for treating and/or reducing reperfusion injury is provided comprising the step of administering to a patient in danger of reperfusion injury a therapeutically effective amount of L-2-oxothiazolidine-4-carboxylic acid. In an embodiment, a method is provided for limiting an expected ischemic reperfusion injury comprising the step of administering prior to an expected ischemic event a therapeutically effective amount of L-2-oxothiazolidine-4-carboxylic acid. In a further embodiment of the present invention, a method is provided for limiting ischemic reperfusion injury comprising the step of administering to a patient after the onset of an ischemic event a therapeutically effective amount of L-2-oxothiazolidine-4-carboxylic acid.
REFERENCES:
patent: 4647571 (1987-03-01), Meister et al.
patent: 4665082 (1987-05-01), Meister et al.
Goldberg Dennis I.
Madsen David C.
Rowe W. Bruce
Clintec Nutrition Co.
Gardner Diane
Waddell Frederick E.
LandOfFree
Method for treating reperfusion injury employing L-2-oxothiazoli does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating reperfusion injury employing L-2-oxothiazoli, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating reperfusion injury employing L-2-oxothiazoli will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2284745